Literature DB >> 21782323

Gastric cancer stem-like cells possess higher capability of invasion and metastasis in association with a mesenchymal transition phenotype.

Lang Yang1, Yi-Fang Ping, Xi Yu, Feng Qian, Zheng-Jun Guo, Cheng Qian, You-Hong Cui, Xiu-Wu Bian.   

Abstract

Cancer stem cells have been isolated from various types of cancer including leukemia and solid tumors. However, the methods for isolating gastric cancer stem-like cells (GCSCs) have not been well established. As a consequence, the biological behavior and the significance of these cells to cancer progression remains to be clarified. In this study, we isolated and characterized GCSCs from a gastric cancer cell line SGC7901 and found their enhanced capabilities of invasion in vitro and metastasis in vivo. We further studied the expression of molecules related to epithelial-mesenchymal and invasion in GCSCs and found there were decreased E-cadherin, but increased vimentin and matrix metalloproteinase 2 (MMP-2), in these cells. Our results suggest that decreased E-cadherin and increased MMP-2 may be associated with the capacity of GCSCs to metastasize.
Copyright © 2011. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21782323     DOI: 10.1016/j.canlet.2011.06.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  31 in total

1.  Activation of toll-like receptor 2 promotes invasion by upregulating MMPs in glioma stem cells.

Authors:  Fan Wang; Peng Zhang; Lang Yang; Xi Yu; Xianzhong Ye; Jing Yang; Cheng Qian; Xia Zhang; You-Hong Cui; Xiu-Wu Bian
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

Review 2.  Gastric cancer stem cells: evidence, potential markers, and clinical implications.

Authors:  Daniel Brungs; Morteza Aghmesheh; Kara L Vine; Therese M Becker; Martin G Carolan; Marie Ranson
Journal:  J Gastroenterol       Date:  2015-10-01       Impact factor: 7.527

Review 3.  Metastatic cancer stem cells: from the concept to therapeutics.

Authors:  Wen-Ting Liao; Ya-Ping Ye; Yong-Jian Deng; Xiu-Wu Bian; Yan-Qing Ding
Journal:  Am J Stem Cells       Date:  2014-09-05

4.  Distinct biological characterization of the CD44 and CD90 phenotypes of cancer stem cells in gastric cancer cell lines.

Authors:  Xiong Shu; Huiqi Liu; Yunzhi Pan; Lichao Sun; Long Yu; Lixin Sun; Zhihua Yang; Yuliang Ran
Journal:  Mol Cell Biochem       Date:  2019-05-09       Impact factor: 3.396

5.  Expression of NUAK2 in gastric cancer tissue and its effects on the proliferation of gastric cancer cells.

Authors:  Lin Tang; Shu-Juan Tong; Zhen Zhan; Qian Wang; Yuan Tian; Feng Chen
Journal:  Exp Ther Med       Date:  2016-12-19       Impact factor: 2.447

6.  Cancer Stem Cells in Tumor Modeling: Challenges and Future Directions.

Authors:  Elvan Dogan; Asli Kisim; Gizem Bati-Ayaz; Gregory J Kubicek; Devrim Pesen-Okvur; Amir K Miri
Journal:  Adv Nanobiomed Res       Date:  2021-06-23

Review 7.  Gastric cancer stem cells: a novel therapeutic target.

Authors:  Shree Ram Singh
Journal:  Cancer Lett       Date:  2013-04-10       Impact factor: 8.679

8.  MicroRNA-183 promotes migration and invasion of CD133(+)/CD326(+) lung adenocarcinoma initiating cells via PTPN4 inhibition.

Authors:  Conghui Zhu; Xi Deng; Jingbo Wu; Jianwen Zhang; Hongru Yang; Shaozhi Fu; Yan Zhang; Yunwei Han; Yuanmei Zou; Zhengtang Chen; Sheng Lin
Journal:  Tumour Biol       Date:  2016-03-07

9.  Transcriptional coexpression network reveals the involvement of varying stem cell features with different dysregulations in different gastric cancer subtypes.

Authors:  Kalaivani Kalamohan; Jayaprakash Periasamy; Divya Bhaskar Rao; Georgina D Barnabas; Srigayatri Ponnaiyan; Kumaresan Ganesan
Journal:  Mol Oncol       Date:  2014-05-09       Impact factor: 6.603

Review 10.  Gastric cancer stem cells: therapeutic targets.

Authors:  Slavica Stojnev; Miljan Krstic; Ana Ristic-Petrovic; Vladisav Stefanovic; Takanori Hattori
Journal:  Gastric Cancer       Date:  2013-04-06       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.